Table 2.

Respiratory function of patient 1 before and after the sargramostim treatment

Date	VC	VC %Ref	FVC (L)	FVC %Ref	FEV1 (L)	FEV1%Ref	FEV1/FVC	FEV1/FVC %Ref	PEF (L/min)	PEF %Ref
Day −82	1.69	55	1.68	53	1.59	56	94	105	7.5	133
Day −70	1.75	56	1.65	51	1.53	52	92.61	101	5.56	97
Day −69 BAL
Day −34	1.56	51	1.52	48	1.39	49	92	102	6.06	107
Day −28	1.64	53	1.62	51	1.5	52	92	103	5.78	102
Day −27 BAL
Day −7	1.7	55	1.59	50	1.5	52	94	105	5.89	104
Day 0	1.66	53	1.59	49	1.49	51	93.24	104	6.15	107
Day +14	1.62	52	1.62	51	1.5	53	93	104	6.52	116
Day +28	1.58	51	1.56	49	1.43	50	91	102	6.38	113
Day +42	1.71	55	1.68	53	1.55	54	92	103	6.38	113
Day +51	1.76	52	1.71	52	1.59	55	93.39	104	6.65	116
Day +78	2.08	67	1.93	60	1.73	61	90	100	6.61	117

BAL bronchoalveolar lavation, VC vital capacity, FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, PEF peak expiratory flow